BeOne Medicines Ltd. Share-Based Compensation 2014-2026 | ONC
What is share-based compensation?
Share-based compensation is the non-cash expense of stock options, restricted stock units, and other equity awards granted to employees.
What is BeOne Medicines Ltd.'s current share-based compensation?
BeOne Medicines Ltd. (ONC) annual share-based compensation for 2025 was $510.2M, a 15.49% increase from 2024. BeOne Medicines Ltd. share-based compensation for the quarter ending March 31, 2026 was $123.3M.
What was BeOne Medicines Ltd.'s share-based compensation in 2024?
BeOne Medicines Ltd. annual share-based compensation for 2024 was $441.8M, a 20.19% increase from 2023.
What was BeOne Medicines Ltd.'s share-based compensation in 2023?
BeOne Medicines Ltd. annual share-based compensation for 2023 was $367.6M, a 21.25% increase from 2022.
What is BeOne Medicines Ltd.'s 5-year share-based compensation CAGR?
BeOne Medicines Ltd. share-based compensation grew at a compound annual growth rate (CAGR) of 22.70% from FY2020 to FY2025, going from $183.5M to $510.2M over 5 years.
Year-over-year comparison from 10-K annual reports